Proper posture reduces the stress on the spine and helps distribute weight more evenly across the back muscles. Stronger muscles help support the spine better, reducing the load and strain on the back. Testosterone is a critical hormone for muscle development and maintenance. Improved mobility can lead to a more active lifestyle, which is crucial for maintaining overall health and well-being. With reduced pain, individuals often find it easier to move around, bend, and perform tasks that were previously challenging. Back pain can severely limit one's ability to move and perform daily activities. Testosterone replacement therapy (TRT) can help improve muscle mass, increase bone density, and support better overall physical function. This happens because testosterone helps maintain strong muscles, healthy bones, and stable posture. While TRT may improve energy, muscle mass, mood, and bone health, it also carries certain risks. Finally, from a mechanistic perspective, assessing the individual and combined effects of intramuscular TRT and finasteride is necessary to impart an understanding of how each drug impacts safety and efficacy in this population and to better discern the influence(s) of testosterone and dihydrotestosterone on tissues of interest. Second, while we comprehensively assessed sex-steroid hormones, including total testosterone and its subfractions, estradiol, dihydrotestosterone, and SHBG, we did not assess gonadotropins, so we cannot discern whether low testosterone was due to primary or secondary causes. First, we enrolled men with low to low–normal testosterone and ambulatory dysfunction after chronic motor-incomplete SCI resulting from trauma, vascular, or orthopedic pathology. Additionally, TRT + finasteride produced negligible PSA change and a lesser prostate size increase than vehicle+placebo (small effect sizes), along with no prostate nodules or indurations, confirming previous studies that report TRT + finasteride may produce lower prostate risk than TRT-alone (25, 32, 33). Similarly, in a rodent SCI model, we have shown that high-dose intramuscular testosterone-enanthate prevented trabecular bone loss at several key sublesional sites, including the femoral neck, distal femur, and proximal tibia, but did not impact cortical bone at these sites (40–42). These improvements contributed to better support for the spine, thereby reducing back pain. Always consult with a healthcare professional to determine if this treatment is right for you. This process helps determine if you are an ideal candidate and ensures that the therapy will be safe and effective for you. Consulting with healthcare providers and considering lifestyle changes can help manage these risks effectively. Balancing the potential benefits and risks is key to deciding if this therapy is right for an individual. More serious risks involve heart health, prostate issues, liver toxicity, and mental health changes. Due to variability in methods used to measure androgens (ELISA in current study, Levy and Schwartz (1973) modification of the Bradlow (1968) method or chemiluminescent microparticle immunoassay and radioimmunoassay in previous studies) it remains challenging to compare the prevalence of low androgen levels across studies. Individuals with paraplegia (as compared to age-matched ABI) had lower luteinizing hormone (LH) and follicle-stimulating hormone (FSH) for two weeks and lower levels of testosterone for six weeks after the injury, subsequently reaching normal levels. Although scarce, studies in the subacute phase of the injury show similar patterns in early testosterone changes. Bivariate plots of changes in androgen sex hormone levels in men with spinal cord injury. In men, median total and free testosterone levels were 12.5 nmol/L (IQR 7.9–17.7) and 27.5 pmol/L (IQR 16.9–36.6), respectively. Finally, previous studies often did not account for SCI characteristics, body morphology, physical activity, underlying comorbidities and medication in their analysis, which all have been shown to influence hormone levels in SCI 1,20,25,26. Comprehensive studies in the subacute phase of the injury are scarce, thus making it difficult to understand the trajectory of early changes in androgen levels following the injury, which is of utmost importance for understanding the role of androgens in modifying metabolic changes, rehabilitation outcomes and functioning post-injury 20,21. The researchers found that after six months of testosterone therapy, many of the men reported significant reductions in pain. Many studies have been conducted to understand how effective testosterone therapy is for back pain. Testosterone therapy can be an effective treatment for back pain in men with low testosterone levels, but it is not suitable for everyone. Increased activity levels contribute to better overall health, creating a positive feedback loop that can enhance the benefits of testosterone therapy. Such spinal deformities can impact a person’s quality of life, leading to mobility issues and increased pain. Low testosterone and bone health issues often result in vertebral compression fractures, where the weakened vertebrae collapse under pressure. Through these mechanisms, testosterone is essential for maintaining bone health, including the strength of the vertebrae in the spine. The increased number of sperm with shorter head lenght in both SCI7 and SCI35 groups, pave the way to consider the crosstalk of sperm and Sertoli cells following SCI induction. Actually, even with maintenance of complete spermatogenesis in mice with chronic SCI, gradual disappearance of proliferating spermatogonia and eventual regression of the seminiferous epithelium were apparent in seminiferous epithelium (5, 8, 15) which was similar to humans (9). Both immediate and time lapse testosterone administration resulted in a significant (P Of note, the same pattern of reduction was seen in the chronic phase. There were no significant differences in the transcription levels of basal and adluminal compartments of the epithelium between control and sham groups.
